An Integrated System of Drug Matching and Abnormal Approval Number Correction

• URL: http://arxiv.org/abs/2207.01543v1
• Date: Fri, 1 Jul 2022 11:19:50 GMT
• Title: An Integrated System of Drug Matching and Abnormal Approval Number Correction
• Authors: Dong Chenxi, QP Zhang, B Hu, JC Zhang, Dl Lin
• Abstract summary: This paper creates an integrated system for matching drug products from two data sources. Our integrated system achieves 98.3% drug matching accuracy, with 99.2% precision and 97.5% recall.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: This essay is based on the joint project with 111, Inc. The pharmacy e-Commerce business grows rapidly in recent years with the ever-increasing medical demand during the pandemic. A big challenge for online pharmacy platforms is drug product matching. The e-Commerce platform usually collects drug product information from multiple data sources such as the warehouse or retailers. Therefore, the data format is inconsistent, making it hard to identify and match the same drug product. This paper creates an integrated system for matching drug products from two data sources. Besides, the system would correct some inconsistent drug approval numbers based on a Naive-Bayes drug type (Chinese or Non-Chinese Drug) classifier. Our integrated system achieves 98.3% drug matching accuracy, with 99.2% precision and 97.5% recall

Related papers

• DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing [4.969453745531116]
  DrugCLIP is a contrastive learning method to learn drug and disease's interaction without negative labels. We have curated a drug repurposing dataset based on real-world clinical trial records.
  arXiv  Detail & Related papers  (2024-07-02T13:41:59Z)
• "Hey..! This medicine made me sick": Sentiment Analysis of User-Generated Drug Reviews using Machine Learning Techniques [2.2874754079405535]
  This project proposes a drug review classification system that classifies user reviews on a particular drug into different classes, such as positive, negative, and neutral. The collected data is manually labeled and verified manually to ensure that the labels are correct.
  arXiv  Detail & Related papers  (2024-04-09T08:42:34Z)
• Learning to Describe for Predicting Zero-shot Drug-Drug Interactions [54.172575323610175]
  Adverse drug-drug interactions can compromise the effectiveness of concurrent drug administration. Traditional computational methods for DDI prediction may fail to capture interactions for new drugs due to the lack of knowledge. We propose TextDDI with a language model-based DDI predictor and a reinforcement learning(RL)-based information selector.
  arXiv  Detail & Related papers  (2024-03-13T09:42:46Z)
• NeuroCADR: Drug Repurposing to Reveal Novel Anti-Epileptic Drug Candidates Through an Integrated Computational Approach [0.0]
  Drug repurposing is an emerging approach for drug discovery involving the reassignment of existing drugs for novel purposes. A proposed algorithm is NeuroCADR, a novel system for drug repurposing via a multi-pronged approach consisting of k-nearest neighbor algorithms (KNN), random forest classification, and decision trees. Data was sourced from several databases consisting of interactions between diseases, symptoms, genes, and affiliated drug molecules, which were then compiled into datasets expressed in binary. NeuroCADR identified novel drug candidates for epilepsy that can be further approved through clinical trials.
  arXiv  Detail & Related papers  (2023-09-04T03:21:43Z)
• Neural Bandits for Data Mining: Searching for Dangerous Polypharmacy [63.135687276599114]
  Some polypharmacies, deemed inappropriate, may be associated with adverse health outcomes such as death or hospitalization. We propose the OptimNeuralTS strategy to efficiently mine claims datasets and build a predictive model of the association between drug combinations and health outcomes. Our method can detect up to 72% of PIPs while maintaining an average precision score of 99% using 30 000 time steps.
  arXiv  Detail & Related papers  (2022-12-10T03:43:23Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
  We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI) MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively. Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
  arXiv  Detail & Related papers  (2022-03-28T05:44:29Z)
• Identifying Illicit Drug Dealers on Instagram with Large-scale Multimodal Data Fusion [18.223055392013542]
  Illicit drug trafficking via social media sites such as Instagram has become a severe problem. How to identify illicit drug dealers from social media data has remained a technical challenge. We propose to tackle the problem of illicit drug dealer identification by constructing a large-scale multimodal dataset.
  arXiv  Detail & Related papers  (2021-08-18T04:29:47Z)
• Two Step Joint Model for Drug Drug Interaction Extraction [82.49278654043577]
  Drug-Drug Interaction (DDI) Extraction from Drug Labels challenge of Text Analysis Conference (TAC) 2018. We propose a two step joint model to detect DDI and it's related mentions jointly. A sequence tagging system (CNN-GRU encoder-decoder) finds precipitants first and search its fine-grained Trigger and determine the DDI for each precipitant in the second step.
  arXiv  Detail & Related papers  (2020-08-28T15:30:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.